HOME >> MEDICINE >> NEWS
Antabuse May Inhibit Fatal Reaction To Anesthetic

UW researchers have concluded studies that may eliminate a fatal problem associated with what is historically one of the most widely used anesthetic agents in the world.

In approximately one in 30,000 patients, the anesthetic agent halothane causes a condition known as "halothane hepatitis," which results in swift and fatal liver damage in approximately 50 percent of cases. For four decades, this problem has been recognized in anesthesia, yet the mechanism by which it occurs has been incompletely understood.

Drug metabolism is the process by which our bodies transform and eliminate the foreign compounds. Halothane is transformed in the liver into a molecule that binds to liver proteins. In most people, this process has no significance, but in some people these liver proteins stimulate the formation of antibodies that seriously damage the liver. The reason why some patients are susceptible remains a mystery.

In a study published in the Lancet in 1996, Dr. Evan Kharasch, professor of anesthesiolofy, identified P450 2E1 as the enzyme responsible for the metabolic step that triggers the formation of antibodies. More recently, Kharasch and colleagues have shown that they can chemically inhibit P450 2E1 from carrying out this unwanted intracellular mission by giving patients a drug called disulfiram before anesthesia.

"We manipulate the activity of the enzyme with disulfiram, known by the trade name Antabuse. We found that a single dose could 'turn off' P450 2E1," Kharasch said.

The disulfiram is itself transformed in the liver into a chemical that inactivates P450 2E1 by binding to it and preventing its catalytic activity. "By turning off this enzyme we can prevent the molecular pathway leading to halothane toxification, and by extrapolation, possibly prevent halothane hepatitis," he said.

Kharasch has identified the role of p450 2E1 in the metabolism of several other volatile anesthetics. The
'"/>

Contact: Will Morton
wmmorton@u.washington.edu
206-543-3620
University of Washington
3-Dec-1998


Page: 1 2

Related medicine news :

1. Inhibitors prevent aggresome formation associated with some forms of ALS
2. Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice
3. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
4. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
5. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
6. Dynavax Demonstrates Ability Of Immunostimulatory DNA Sequences To Inhibit Symptoms Of Allergic Asthma In Animal Model
7. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
8. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
9. Answers To Access, Adherence And Tolerance Of Protease Inhibitors
10. ACE-Inhibitors Score High In Reducing Heart Attack Deaths
11. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... In the past, one of the first steps ... was often the reason many patients did not have a hair transplant. According to ... for men to get the hairline they desire without shaving their head. This method ...
(Date:2/19/2019)... ... February 19, 2019 , ... WEDI , the nation’s ... information exchange and a statutory advisor to the U.S. Department of Health and Human ... Charles Stellar. The statement was issued following the release last week at the HIMSS ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... and development solutions for drugs, biologics and consumer health products, today announced ... annual US Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA), ...
(Date:2/19/2019)... ... ... Seafood Nutrition Partnership (SNP) is pleased to announce Jacqueline Claudia ... and Co-Founder of LoveTheWild , an award-winning frozen seafood line that is making ... is a self-proclaimed “fish nerd” with a passion for the sustainable aquaculture industry. ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... system needs to improve care outcomes and patient experiences. Through the End2End ... journeys and audiences in key areas: , 1. Access Manager enhances engagement ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... ... ExceleraRx Corporation announced today that St. Luke’s Health System has joined the ... the state of Idaho. , “We are very pleased to welcome St. ... Corp. “We believe St. Luke’s commitment to expanding and leveraging its pharmacy capabilities to ...
(Date:2/19/2019)... ... , ... The Jean Griswold Foundation, a nonprofit named for the founder of ... lives of seniors and others in the communities in which Griswold Home Care operates. ... couldn’t afford them. , “Each of these organizations have made such an ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... Florida, has completed his new book “Live Hard Die Young.” Dr. Oexner was ... practices chiropractic medicine, therapeutic exercise physiology, and nutritional counseling. Dr. Oexner was a ...
Breaking Medicine Technology:
Cached News: